AI PRICE FORECAST
CVS Stock Forecast & AI Price Prediction
CVS Health · Healthcare · Healthcare Plans
CVS live signal snapshot
CVS last traded at $89.52, up 0.57% on the session, trading 19.1% below its 52-week high of $110.68 and 28.8% above its 52-week low of $69.51. Stock Pulse 247's AI model currently rates CVS a HOLD, at 69% model confidence. The technical signals aren't aligned enough for a directional call yet. Short-term momentum is deteriorating: the 5-, 10- and 20-day moving averages are stacked downward and price is holding below the 50-day average. The model's one-month path points toward roughly $93.27 (4.2% from here).
On the 14-day relative strength index, CVS reads 43.3, drifting toward the 30 line that marks oversold conditions. Its MACD line is below its signal line with a negative histogram (-0.16) — downward momentum is accelerating. The 50-day moving average ($89.97) sits 1.1% above the 200-day ($89.02) — a "golden cross" structure that typically supports the longer-term uptrend.
The average 12-month target from 25 Wall Street analysts is $110.32 (range $86.00–$146.00) — 23.2% upside from where CVS trades now. The current recommendation trend leans bullish: 25 Buy/Strong Buy ratings vs 0 Sell/Strong Sell (and 3 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive CVS dashboard for numbers updated throughout today's session.
About CVS Health
CVS Health Corporation (CVS) is a healthcare plans company in the healthcare sector, headquartered in Woonsocket, RI, United States. CVS Health Corporation provides health solutions in the United States. It has a market value of about $114.5 billion and roughly 219,000 full-time employees. With a beta of 0.58, the stock has historically moved less than the overall market.
CVS performance vs. the market
Since the start of 2026 the stock has risen 12.8%, ahead of the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). On a one-year view it is up 15.5%, 4.0 points better than the S&P 500. Momentum has recently turned: +2.3% in the last month against −5.8% over three months.
| Period | CVS | Sector (XLV) | S&P 500 |
|---|---|---|---|
| 1 month | +2.3% | +11.4% | −2.3% |
| 3 months | −5.8% | +12.2% | −2.3% |
| Year to date | +12.8% | +22.1% | +11.4% |
| 1 year | +15.5% | +28.3% | +11.5% |
CVS Health financials at a glance
In the quarter ended Sep 30, 2026, CVS Health reported revenue of $108.4 billion and net income of $2.2 billion (a 2.0% net margin). Revenue was up 5.4% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 10.4 on trailing earnings of $8.61 per share. Trailing free cash flow was $11.8 billion, and total debt equals 93% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $108.4B | $2.2B |
| Jun 30, 2026 | $106.1B | $3.0B |
| Mar 31, 2026 | $100.4B | $2.9B |
| Dec 31, 2025 | $105.7B | $2.9B |
CVS vs. its peers
Against 5 of its largest healthcare peers, CVS's +12.8% year-to-date return beats 1 of them. The strongest of the group this year is Humana (HUM, +74.3%).
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| CVS Health (CVS) | $89.52 | +12.8% | 10.4 | HOLD |
| UnitedHealth Group (UNH) | $402.94 | +22.1% | 23.0 | HOLD |
| Elevance Health (ELV) | $429.48 | +22.5% | 18.2 | HOLD |
| The Cigna Group (CI) | $301.45 | +9.5% | 13.3 | HOLD |
| Humana (HUM) | $446.31 | +74.3% | 43.5 | BUY |
| Eli Lilly and (LLY) | $1,437.29 | +33.7% | 46.7 | BUY |
CVS stock: common questions
What is the CVS stock price target?
25 Wall Street analysts put the average 12-month target at $110.32, in a range of $86.00–$146.00, versus a recent price of $89.52. Stock Pulse 247's model projects about $93.27 over the next month.
Is CVS a buy right now?
Our AI model currently rates CVS a HOLD at 69% confidence. Among analysts, 25 rate it Buy or Strong Buy, 3 Hold and 0 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has CVS stock performed this year?
Since the start of 2026 the stock has risen 12.8%, ahead of the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). On a one-year view it is up 15.5%, 4.0 points better than the S&P 500. Momentum has recently turned: +2.3% in the last month against −5.8% over three months.
What is CVS's 52-week high and low?
CVS has traded between $69.51 and $110.68 over the past 52 weeks; at $89.52 it is 19.1% below its 52-week high of $110.68 and 28.8% above its 52-week low of $69.51.
What sector is CVS in, and who are its peers?
CVS is in the healthcare sector (healthcare plans). Its largest peers on Stock Pulse 247 include UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), Humana (HUM).
How accurate is the CVS forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines CVS's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.